novo-group-foundation-54.html
Novo Annual Report 2015
55 / 72
t he novo nordisk
foundation
is an independent danish
foundation
that dates back to the 1920s. the objectives of the
foundation
are: ? to provide a stable basis for the commercial and
research
activities conducted by the companies in the novo group; ? to support scientific, humanitarian and social purposes. through its activities, the
foundation
aims to promote world- class
research
and innovation in medical, biotechnological and natural sciences and help to foster an education system of international standard. the
foundation
also aims to help develop a knowledge- based society that contributes to long-term economic activity and job creation for improved health and welfare, with denmark as the
foundation
?s centre of gravity. the ambition is that the
foundation
?s grants facilitate the emergence of new and pioneering
research
and help to create dynamic international
research
environments that can attract and retain the very best
research
ers. by generating
research
-based products and services it is the
foundation
?s ambition that the novo group companies will position themselves as internationally recognized actors in the combatting of diseases and the more intelligent use of natural resources. the
foundation
finances its activities primarily through dividends from novo a/s, which administers the assets of the
foundation
. supporting independent
research
the
foundation
supports
research
at universities and hospitals in the nordic countries, primarily denmark. the board of the
foundation
specifies the grant areas, grant types and the financial terms for funding. within this framework, the
foundation
ensures that each project application is assessed by independent
research
experts before a grant decision is made. all grants awarded by the
foundation
support free and independent
research
. the
research
ers decide their own
research
priorities; they can publish as they wish, and the ipr belongs to the public
research
institutions. in recent years, the
foundation
has become one of the largest private contributors of funding to biomedical and biotechnological
research
in the danish public sector. major grants since 2007, the
foundation
has donated close to
dkk
7 billion ( ? 922 million) primarily for
research
purposes. these grants include
dkk
3.5 billion to establish and develop the novo nordisk
foundation
?s
research
centre cluster, which comprises a national biobank and four major
research
centres within the fields of stem cells, proteins, metabolism and biosustainability at universities or public knowledge institutions in the greater copenhagen area. in 2015, the
foundation
also announced its plan to award up to
dkk
2.8 billion for the steno diabetes center copenhagen ? a major new diabetes center which will be an international driving force for treatment of, and clinical
research
into diabetes. selected grant activities 2015 in 2015, the novo nordisk
foundation
has awarded grants totaling
dkk
1,159 million, including: ?
dkk
235 million to strengthen and expand the activities of the novo nordisk
foundation
section for basic stem cell biology. ?
dkk
572 million for individual
research
projects and scholar-/fellowships, awarded in open competition through the
foundation
?s expert committees, including
dkk
120 million for the novo nordisk
foundation
challenge programme which this year addresses microbiome
research
, and
dkk
10 million for exploratory pre-seed grants. ?
dkk
80 million for
research
into immunometabolism. ?
dkk
25 million to pre-seed projects (in collaboration with novo seeds). ?
dkk
20 million for an international mentor network to help develop promising early-stage commercialisation projects. ?
dkk
7.6 million to art-related
research
. ?
dkk
7 million for humanitarian and social causes. the
foundation
?s total pay-out amounted to
dkk
914 million in 2015. for more information, please visit www.novonordiskfonden.dk annual review 2015 55 novo nordisk
foundation
nordisk-novo-diabetes-56.html
